New Implant Coatings Make Them More Biocompatible
By HospiMedica International staff writers Posted on 09 Jul 2020 |
Image: Macrophages on implants coated with heparin (L) and HA (R) (Photo courtesy of Hala Al Khoury / MLU)
A new method of applying anti-inflammatory substances can inhibit undesirable inflammatory reactions to implants, claims a new study.
Researchers at the Martin Luther University Halle-Wittenberg (MLU; Halle-Wittenberg; Germany), the University of Niš (Serbia), and other institutions conducted a study to examine the anti-inflammatory properties of surface coatings made of either hyaluronic acid (HA) or heparin (H) in combination with chitosan, prepared as multilayers through a layer-by-layer deposition technique. The properties of the glycosaminoglycan (GAG)-modified surfaces were then characterized in terms of surface topography, thickness, and wettability.
The results showed a higher thickness and hydrophilicity after multilayer formation. The multilayers containing either HA or H dampened the inflammatory response visible by reduced adhesion, formation of multinucleated giant cells and interleukin release, and a significant decrease in macrophages on GAG-based multilayers, with the macrophages able to associate with and take up both HA and H. Overall, the heparin-based multilayers demonstrated the most suppressive effect on macrophage activation after implantation of medical devices. The study was published on May 25, 2020, in the International Journal of Molecular Sciences.
“The immune system attracts various cells that try to isolate or remove the foreign entity; these include macrophages. This is kind of tricky, because we obviously do not want to completely turn off the immune system as its processes are vital for healing wounds and killing pathogens,” said senior author Professor Thomas Groth, PhD, of the MLU Institute of Pharmacy. “Both heparin and hyaluronic acid prevent the release of certain pro-inflammatory messenger substances. Heparin is even more effective because it can be absorbed by macrophage cells.”
Chitosan is a linear polysaccharide composed of randomly distributed glucoseamine deacetylated unit and acetylated units. It is made by treating shrimp and other crustacean shells with the alkali sodium hydroxide. Chitosan also has a number of commercial uses, such as a seed treatment and biopesticide, helping plants to fight off fungal infections. In winemaking it can be used as a fining agent, and it can also be used in self-healing polyurethane paint coating.
Related Links:
Martin Luther University Halle-Wittenberg
University of Niš
Researchers at the Martin Luther University Halle-Wittenberg (MLU; Halle-Wittenberg; Germany), the University of Niš (Serbia), and other institutions conducted a study to examine the anti-inflammatory properties of surface coatings made of either hyaluronic acid (HA) or heparin (H) in combination with chitosan, prepared as multilayers through a layer-by-layer deposition technique. The properties of the glycosaminoglycan (GAG)-modified surfaces were then characterized in terms of surface topography, thickness, and wettability.
The results showed a higher thickness and hydrophilicity after multilayer formation. The multilayers containing either HA or H dampened the inflammatory response visible by reduced adhesion, formation of multinucleated giant cells and interleukin release, and a significant decrease in macrophages on GAG-based multilayers, with the macrophages able to associate with and take up both HA and H. Overall, the heparin-based multilayers demonstrated the most suppressive effect on macrophage activation after implantation of medical devices. The study was published on May 25, 2020, in the International Journal of Molecular Sciences.
“The immune system attracts various cells that try to isolate or remove the foreign entity; these include macrophages. This is kind of tricky, because we obviously do not want to completely turn off the immune system as its processes are vital for healing wounds and killing pathogens,” said senior author Professor Thomas Groth, PhD, of the MLU Institute of Pharmacy. “Both heparin and hyaluronic acid prevent the release of certain pro-inflammatory messenger substances. Heparin is even more effective because it can be absorbed by macrophage cells.”
Chitosan is a linear polysaccharide composed of randomly distributed glucoseamine deacetylated unit and acetylated units. It is made by treating shrimp and other crustacean shells with the alkali sodium hydroxide. Chitosan also has a number of commercial uses, such as a seed treatment and biopesticide, helping plants to fight off fungal infections. In winemaking it can be used as a fining agent, and it can also be used in self-healing polyurethane paint coating.
Related Links:
Martin Luther University Halle-Wittenberg
University of Niš
Latest Surgical Techniques News
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery
- Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions
- Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons
- Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots
- Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices
- Custom 3D-Printed Orthopedic Implants Transform Joint Replacement Surgery
- Wearable Technology Monitors and Analyzes Surgeons' Posture during Long Surgical Procedures
- Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery
- Computational Models Predict Heart Valve Leakage in Children
- Breakthrough Device Enables Clear and Real-Time Visual Guidance for Effective Cardiovascular Interventions
- World’s First Microscopic Probe to Revolutionize Early Cancer Diagnosis
- World’s Smallest Implantable Brain Stimulator Demonstrated in Human Patient
- Robotically Assisted Lung Transplants Could Soon Become a Reality
- AI to Provide Heart Transplant Surgeons with New Decision-Making Data
- New Surgical Tool Empowers Precision and Confidence in Operating Room